Prof. Dr. Sami Siraj
Biography
Professor of Pharmacology & Director, Institute of Pharmaceutical Sciences, Khyber Medical University
Prof. Dr. Sami Siraj is a Professor of Pharmacology and Director of the Institute of Pharmaceutical Sciences (IPS), Khyber Medical University, Peshawar. He holds a PhD in Pharmacology from China Pharmaceutical University, China, an MPhil in Molecular Biology from the University of the Punjab, and a Bachelor of Pharmacy from Gomal University.
With extensive experience in pharmaceutical education, research, and academic leadership, his research focuses on pharmacogenomics, precision medicine, precision oncology, β-thalassemia genetics and therapeutics, and cardiovascular pharmacogenetics. His work explores genetic and molecular determinants of drug response and their application in personalized and predictive healthcare.
Prof. Dr. Sami Siraj has supervised 22 MPhil and 1 PhD graduates and currently supervises 5 MPhil and 5 PhD scholars. He has also contributed to numerous national and international research collaborations and has served in various academic and professional capacities.
He has 72 research publications in peer-reviewed scientific journals and has received the Best University Teacher Award (KMU-HEC), 2021–2022. His academic and research contributions continue to strengthen pharmaceutical education, precision medicine, and translational research at IPS and beyond.
Research Interests
Pharmacogenomics & Precision Medicine
Publications
- Impact of ABCB1 gene polymorphism on clopidogrel plasma concentration and cardiovascular events in post-PCI patients — Abdur Razaq, Waheed Iqbal, Syed Tahir Shah, Muhammad Abdur Rauf, Nasser M Aldekhail, Filip Van Nieuwerburgh, Sami Siraj , journal (2026)
- Impact of gender on long-term clinical outcomes and major adverse cardiovascular events in patients undergoing percutaneous coronary intervention receiving clopidogrel therapy: A follow-up study — Waheed Iqbal, Abdur Razaq, Syed Tahir Shah, Shafiq Ahmad Tariq, Sheema Rahim, Sami Siraj , journal (2026)
- Ambroxol’s Role in PTZ-Induced Anxiety-Like Conditions in Mice: Targeting Neuroinflammation and Oxidative Stress via In Vivo and In Silico Approaches — Hafeeza Zafar Ali, Sarwat Jahan, Laila Ilahi, Sami Siraj, Muhammad Zakria, Najeeb Ullah, Muhammad Ikram, Ashraf Ullah Khan, Manzoor Khan, Fawad Ali Shah & Hafsah Muhammad , journal (2025)
- Impact of CYP2C19*2 on Clopidogrel Response and Cardiovascular Outcomes in ST-segment elevation myocardial infarction Patients — Abdur Razaq 1, Waheed lqbal 2, Syed Tahir Shah 3, Mohsin Ali 4, Sami Siraj 5, , journal (2026)
- Association of CYP2C19 gene single nucleotide polymorphisms (rs12248560 and rs4244285) with response to thalidomide in transfusion dependent β-thalassemia patients- a 12-months follow-up study — Inayat Ur Rahman, Muhammad Shahid, Muhammad Tariq Humayun Khan, Naseer Ahmed, Shafiq Ahmad, Amir Muhammad, Sher Afghan Khan, Abdus Saboor, Muhammad Tariq Masood Khan, Sami Siraj , journal (2025)
- Association of ABCC2 gene polymorphism (rs3740066) with thalidomide-induced peripheral neuropathy in transfusion-dependent β-thalassemia patients: a case–control study from … — Shafiq Ahmad, Sami Siraj, Inayat Ur Rahman, Muhammad Shahid, Ghazala Shaheen, Umar Aleem , journal (2025)